Boys washing out of eteplirsen to participate in suvodirsen trial. | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website


  • Get 3 months of ad-free premium service for every $25 you contribute
    to support critical site improvement efforts.
    With no recurring subscription
    to worry about, this an ideal way to test drive our premium service.

    Premium features, such as multi-message viewing (i.e., being able to open
    up to 100 messages with a single click) can save you lots of time
    over the course of a busy day, to say nothing of an entire year!
    Watch this 2-min video to see why premium is right for you.


    *Offer expires at midnight

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  13794 of 13964  at  6/8/2019 10:19:09 AM  by

pineappleguava


 In response to msg 13791 by  schmiggins
view thread

Re: Boys washing out of eteplirsen to participate in suvodirsen trial.

Schmiggins - the company's targets have slipped, priorities changed without a word. One of the tweeters posted something about a business decision surrounding the abandonment of antibiotics and seems out of touch with how many employees the Company publishes hiring. But heck what's the difference between 100 versus over 150. At the rate new employees have streamed through the doors in the past two years it is a wonder any programs have made progress let alone gain focus.

The exon skipping programs are languishing. The company's first phase 3 program had an ignored completion date come and go [no surprise]. The ongoing "extension" study of the phase 2 on the original 12 boys is still listed both on the clinical trial site and Sarepta's website. Only on the clinical trial site it is listed as unknown status with the last company update in 2016. Is that because some of the original boys in the trial are only assessing exondys 51 through this trial?

The once promising science of morpholinos seems to have been shoved to the side.

A recent glassdoor review of working at Sarepta. "Pros - Decent Salary. Catered Lunch on Weds/Fri. Free Snacks. Ok Benefits (Stock Options and RSUs)" "Cons - "Departments do not work together as a team. -No one want to take responsibilities."



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 195
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...